Literature DB >> 17318790

Interactions between apelin and angiotensin II on rat portal vein.

Bogdan Gurzu1, Bogdan Cristian Petrescu, Marcel Costuleanu, Gheorghe Petrescu.   

Abstract

Apelin (AP), an endogenous ligand of the APJ receptor, is involved in the regulation of cardiovascular homeostasis. Regardless the multiple similarities between AP and angiotensin II (Ang II), their roles seem to be different. We studied both the interactions between Apelin 13 (AP13) and Ang II and to what extent, if any, nitric oxide (NO) is involved. The experiments were performed in endothelium-denuded or endothelium-intact rat portal vein in the presence of 10 microM N(G)-nitro L-arginine methyl ester or 10 microM aminoguanidine. AP13 did not modify the isolated rat portal vein tone by itself, but inhibited the Ang II-induced contractions acting mainly by a NO-dependent mechanism. Our results sustain the hypothesis that AP13 could increase the activity of both constitutive and inducible NO synthase on either endothelium intact or endothelium denuded rat portal vein rings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17318790     DOI: 10.3317/jraas.2006.040

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  15 in total

Review 1.  Vascular effects of apelin: Mechanisms and therapeutic potential.

Authors:  Amreen Mughal; Stephen T O'Rourke
Journal:  Pharmacol Ther       Date:  2018-05-25       Impact factor: 12.310

Review 2.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

Review 3.  Effects of apelin on the cardiovascular system.

Authors:  Anna Folino; Pier Giorgio Montarolo; Michele Samaja; Raffaella Rastaldo
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

4.  Activation of Large Conductance, Calcium-Activated Potassium Channels by Nitric Oxide Mediates Apelin-Induced Relaxation of Isolated Rat Coronary Arteries.

Authors:  Amreen Mughal; Chengwen Sun; Stephen T O'Rourke
Journal:  J Pharmacol Exp Ther       Date:  2018-05-17       Impact factor: 4.030

5.  Apelin and pulmonary hypertension.

Authors:  Charlotte U Andersen; Ole Hilberg; Søren Mellemkjær; Jens E Nielsen-Kudsk; U Simonsen
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

6.  Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.

Authors:  Seyyed M R Kazemi-Bajestani; Vaibhav B Patel; Wang Wang; Gavin Y Oudit
Journal:  Cardiol Res Pract       Date:  2012-05-13       Impact factor: 1.866

7.  The role of apelin on the alleviative effect of Angiotensin receptor blocker in unilateral ureteral obstruction-induced renal fibrosis.

Authors:  Masashi Nishida; Yasuko Okumura; Tatsujiro Oka; Kentaro Toiyama; Seiichiro Ozawa; Toshiyuki Itoi; Kenji Hamaoka
Journal:  Nephron Extra       Date:  2012-03-07

8.  Association of SNP Rs9943582 in APLNR with Left Ventricle Systolic Dysfunction in Patients with Coronary Artery Disease in a Chinese Han GeneID Population.

Authors:  Pengyun Wang; Chengqi Xu; Chuchu Wang; Yanxia Wu; Dan Wang; Shanshan Chen; Yuanyuan Zhao; Xiaojing Wang; Sisi Li; Qin Yang; Qiutang Zeng; Xin Tu; Yuhua Liao; Qing K Wang; Xiang Cheng
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

Review 9.  Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.

Authors:  Peiran Yang; Janet J Maguire; Anthony P Davenport
Journal:  Trends Pharmacol Sci       Date:  2015-07-01       Impact factor: 14.819

10.  Apelin Does Not Impair Coronary Artery Relaxation Mediated by Nitric Oxide-Induced Activation of BKCa Channels.

Authors:  Amreen Mughal; Chengwen Sun; Stephen T O'Rourke
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.